- Home
- BETR vs VSTM Comparison
BETR vs VSTM Comparison
Compare BETR & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BETR | VSTM |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.7M | 470.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | BETR | VSTM |
|---|---|---|
| Price | $25.47 | $4.13 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $40.00 | $16.50 |
| AVG Volume (30 Days) | 549.9K | ★ 2.1M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,914,000.00 |
| Revenue This Year | $55.02 | $282.64 |
| Revenue Next Year | $65.66 | $72.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $10.81 | $4.01 |
| 52 Week High | $94.06 | $11.25 |
Technical Indicators
Market Signals| Indicator | BETR | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 28.52 |
| Support Level | N/A | N/A |
| Resistance Level | $35.07 | $6.67 |
| Average True Range (ATR) | 2.88 | 0.34 |
| MACD | -1.65 | -0.15 |
| Stochastic Oscillator | 4.01 | 0.56 |
Price Performance
Historical ComparisonAbout BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.